Behandelingen voor genetische neurocognitieve aandoeningen
-
Published:2013-10
Issue:5
Volume:17
Page:132-138
-
ISSN:1387-5817
-
Container-title:Neuropraxis
-
language:nl
-
Short-container-title:NEUROPRAXIS
Author:
Overwater Iris,van der Vaart Thijs,De Wit Marie-Claire,Oostenbrink Rianne,Elgersma Ype
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Bissler, J.J., Kingswood, J.C., Radzikowska, E., Zonnenberg, B.A., Frost, M., Belousova, E., Sauter, M., Nonomura, N., Brakemeier, S., Vries, P.J. de, Whittemore, V.H., Chen, D., Sahmoud, T., Shah, G., Lincy, J., Lebwohl, D. & Budde, K. (2013). Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST –2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet, Jan 10. pii: S0140–6736(12)61767–X. doi: 10.1016/S0140–6736(12)61767-X 2. Costa, R.M., Federov, N.B., Kogan, J.H., Murphy, G.G., Stern, J., Ohno, M., Kucherlapati, R., Jacks, T. & Silva, A.J. (2002). Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature, 415, 6871, 526–530. 3. Cui, Y., Costa, R.M., Murphy, G.G., Elgersma, Y., Zhu, Y., Gutmann, D.H., Parada, L.F., Mody, I. & Silva, A.J. (2008). Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning. Cell, 135, 3, 549–560. doi: 10.1016/j.cell.2008.09.060 4. Davies, D.M., Vries, P.J. de, Johnson, S.R., McCartney, D.L., Cox, J.A., Serra, A.L., Watson, P.C., Howe, C.J., Doyle, T., Pointon, K., Cross, J.J., Tattersfield, A.E., Kingswood, J.C. & Sampson, J.R. (2011). Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clinical Cancer Research, 17, 12, 4071–4081. doi: 10.1158/1078–0432.CCR –11–0445 5. Descheemaeker, M.J., Plasschaert, E., Frijns, J.P. & Legius, E. (2012). Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group. Journal of Intellectual Disability Research, Epub Oct 24. doi: 10.1111/j.1365–2788.2012.01648
|
|